Brief: Pediapharm Announces Q2 Revenue $3.1 Mln Versus $1.9 Mln
Nov 27 (Reuters) - Pediapharm Inc PDP.V :
* PEDIAPHARM ANNOUNCES Q2 RECORD REVENUE AND FIRST-EVER
ADJUSTED
EBITDA POSITIVE QUARTER
* PEDIAPHARM INC - IN THREE-MONTH PERIOD ENDED SEPT 30,
2017,
QUARTERLY REVENUE OF $3.1 MILLION VERSUS $1.9 MILLION
* PEDIAPHARM INC - QTRLY NET LOSS AND COMPREHENSIVE LOSS
$336,631
VERSUS QTRLY NET LOSS AND COMPREHENSIVE LOSS OF $838,321
Source text for Eikon: ID:nCCNtRpl7a
Further company coverage: PDP.V
((Bangalore.newsroom@thomsonreuters.com;;))
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million